Stockreport

Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]

Alterity Therapeutics Limited - American Depositary Shares  (ATHE) 
PDF – Baseline Biomarker Data to be Presented from Ongoing ATH434-201 Phase 2 Clinical Trial – MELBOURNE, Australia and SAN FRANCISCO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- A [Read more]